Sushanto Kumar Saha, Cansu Umran Tunc, Nitish Khurana, Jason William Grunberger, Hamidreza Ghandehari
{"title":"Effects of silica nanoparticles with varied physicochemical properties on the survival and functionality of saturated macrophages","authors":"Sushanto Kumar Saha, Cansu Umran Tunc, Nitish Khurana, Jason William Grunberger, Hamidreza Ghandehari","doi":"10.1016/j.jconrel.2025.113640","DOIUrl":null,"url":null,"abstract":"Silica nanoparticles (SNPs) have shown potential as nanocarriers in diagnostic, imaging, and drug delivery applications. To use SNPs for systemic drug delivery, it is important to have a detailed understanding of how these particles interact with the mononuclear phagocytic system (MPS). Whether or not SNPs may saturate the macrophages, thereby influencing their function and impairing innate immune responses, remains poorly understood. In this work, we defined macrophage saturation using RAW 264.7 macrophages as a model and studied four SNPs with variations in size and porosity. We further explored the downstream effects of SNP uptake by macrophages, including apoptosis/necrosis, cell cycle progression, membrane integrity, and phagocytic activity. The data demonstrate that SNPs do not alter major cellular functions at their respective nontoxic, saturating concentrations.","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"17 1","pages":""},"PeriodicalIF":10.5000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jconrel.2025.113640","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
摘要
二氧化硅纳米颗粒(SNPs)作为纳米载体在诊断、成像和药物输送应用方面已显示出潜力。要将 SNP 用于全身给药,必须详细了解这些颗粒如何与单核吞噬系统(MPS)相互作用。至于 SNP 是否会使巨噬细胞饱和,从而影响其功能并损害先天性免疫反应,目前仍然知之甚少。在这项工作中,我们以 RAW 264.7 巨噬细胞为模型定义了巨噬细胞饱和度,并研究了四种大小和孔隙率不同的 SNP。我们进一步探讨了巨噬细胞吸收 SNP 的下游效应,包括细胞凋亡/坏死、细胞周期进展、膜完整性和吞噬活性。数据表明,在各自的无毒饱和浓度下,SNP 不会改变主要的细胞功能。
Effects of silica nanoparticles with varied physicochemical properties on the survival and functionality of saturated macrophages
Silica nanoparticles (SNPs) have shown potential as nanocarriers in diagnostic, imaging, and drug delivery applications. To use SNPs for systemic drug delivery, it is important to have a detailed understanding of how these particles interact with the mononuclear phagocytic system (MPS). Whether or not SNPs may saturate the macrophages, thereby influencing their function and impairing innate immune responses, remains poorly understood. In this work, we defined macrophage saturation using RAW 264.7 macrophages as a model and studied four SNPs with variations in size and porosity. We further explored the downstream effects of SNP uptake by macrophages, including apoptosis/necrosis, cell cycle progression, membrane integrity, and phagocytic activity. The data demonstrate that SNPs do not alter major cellular functions at their respective nontoxic, saturating concentrations.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.